Growth Metrics

Protalix BioTherapeutics (PLX) Operating Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 119.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 119.66%
Dec 31, 2025 -26.93%
Sep 30, 2025 38.94%
Jun 30, 2025 30.30%
Mar 31, 2025 -30.39%
Dec 31, 2024 48.33%
Sep 30, 2024 60.28%
Jun 30, 2024 35.79%
Mar 31, 2024 -9.44%
Dec 31, 2023 -58.45%
Sep 30, 2023 9.92%
Jun 30, 2023 123.18%
Mar 31, 2023 -36.15%
Dec 31, 2022 50.48%
Sep 30, 2022 -26.49%
Jun 30, 2022 1.83%
Mar 31, 2022 30.35%
Dec 31, 2021 -15.83%
Sep 30, 2021 20.43%
Jun 30, 2021 -10.77%
Mar 31, 2021 10.40%
Dec 31, 2020 31.93%
Sep 30, 2020 30.72%
Jun 30, 2020 40.82%
Mar 31, 2020 39.89%
Dec 31, 2019 31.08%
Sep 30, 2019 38.53%
Jun 30, 2019 16.22%
Mar 31, 2019 11.05%
Dec 31, 2018 21.87%
Sep 30, 2018 9.23%
Jun 30, 2018 -6.49%
Mar 31, 2018 1.46%
Mar 31, 2017 0.53%
Dec 31, 2016 20.10%
Sep 30, 2016 -5.60%
Jun 30, 2016 -12.94%
Mar 31, 2016 -21.09%
Dec 31, 2015 8.85%
Sep 30, 2015 3.46%
Jun 30, 2015 -37.16%
Mar 31, 2015 3.89%
Mar 31, 2014 -8.69%
Dec 31, 2013 -24.55%
Sep 30, 2013 -25.61%
Jun 30, 2013 12.10%